Continuous administration of albumin (for 3 consecutive days or more) to adult patients with severely or critically ill COVID‐19, hypoproteinemia, septic shock, or sepsis can restore plasma albumin levels and improve prognosis (Figure 4B). The gene discussed is ALB; the disease is COVID-19.